# Biophysical Therapeutics Anti-Aging Breakthrough from PhDs - Canonical URL: https://wefunder.com/biophysical.therapeutics - Entity ID: wefunder:company:130890 - Last updated: 2026-06-11T23:52:40Z - Generated at: 2026-06-12T03:38:11Z ## Quick facts - Professor George Church (Harvard Medical School) is advisor. - Discovered nature's dial for aging rate, which sets different species with different lifespans. - The dial is IF1 protein, more confers slower aging, which we'll use in our skincare. - Have paid pre-orders ($120 per unit). - Demand and highly profitable unit economics already shown. - Everyone ages. ## Active fundraises - wefunder:fundraise:165120: 4(a)(6) open (USD) - wefunder:fundraise:80242: 4(a)(6) successful (USD) - wefunder:fundraise:80243: 4(a)(6) successful (USD) ## Story Aging and looking older is unwanted.In nature, different species have different aging rates and lifespans. So, nature knows how to modify aging rate, which (according to data and analysis) we've discovered. Where more IF1 protein slows aging, which we will bottle in a skin moisturizer called IF1.Patents filed.Raising $50k to manufacture and sell the first 500 units.Already have paid pre-orders ($120 each). Moreover, incredible unit economics data from paid ads experiments.THE SCIENCEA bowhead whale can live centuries longer than a mouse. One of the greatest mysteries in science is how different species can have such different lifespans.The highest level of evidence in science, the gold-standard (e.g., Einstein), is a quantitative explanation that can successfully predict.Dr. Michael Forrest’s quantitative, mechanistic account of aging (completely parameterized by experimental data) can blindly but faithfully predict the lifespans of thousands of unseen species. Its pre-specified causal chain is checked and corroborated at forty different points by instrumental variable analysis of experimental data, an advanced technique that can detect causality. Controlling this chain is IF1 protein; increasing IF1 protein in mice reduces aging as measured by an aging biomarker. The chance of all this occurring by chance is nearly zero (smaller than one divided by the number of atoms in the universe).Further detail:With this scientific support, an anti-aging skin moisturizer containing IF1 protein (or a derivative thereof) is differentiated from others. Biophysical Therapeutics is a Delaware company founded by Dr. Forrest, which boasts the famous Professor George Church (Harvard Medical School) as an advisor. It will be providing such a skin moisturizer under its IF1 brand at www.IF1.skin.Refer to the website for more information. It links to a corresponding preprint paper, titled IF1 Protein Controls Aging Rate, although the work has progressed substantially further in the same direction since it was published.DEMONSTRATED CONSUMER DEMANDUSP: greater scientific substantiation than any other anti-aging skincare product on the market.We've validated demand and demonstrated highly profitable unit economics from advertising on Google, Reddit, Facebook, and Instagram. Where an interested website visitor (from the USA) can be bought for between 50 cents to 1 dollar, and 11% (103 of 930) of these website visitors - after seeing the $120 per unit price - click its Buy button. Suggesting a Customer Acquisition Cost (CAC) of 5 to 10 dollars. For a consumable product that costs $120, lasts around a month of daily use, yielding $1,440 revenue per year. After pressing the Buy button they're told that the product isn't for sale yet, we're not sure when it will be, inviting them to pay the full $120 amount upfront anyway. Incredibly, seven people did this. The present raise is to fulfill demonstrated consumer demand.Manufacturing the first batch of units is much more expensive than subsequent batches for which the cost of goods is projected low. Manufacturing within the USA: partner selected and costed.Raising $50k to hit first 500 fulfilled sales, revenue, and profit. This profit is projected sufficient to manufacture a further, larger batch thereafter; iterating this, ratcheting scale and profit. This flywheel (at least initially) driven by our positive unit economics with online ads, meaning more money in gets more money out.Anti-aging skincare market size is $80B, growing 10% per year.780 sales per day to be a unicorn (estimate).Everyone ages. ANTICANCERThe company also has medical programs. For example, its new cancer drug candidate that - as Dr. Forrest designed - has been shown to harm cancer but not normal cells in vitro, including in independent testing at the National Cancer Institute (USA). A one minute read summary of this anticancer program is HERE.Dr. Michael Forrest is a Cambridge University biochemistry graduate with a Ph.D. in computer science. An authority on computational biology, moreover, a drug inventor with granted patents.BIOPHYSICAL THERAPEUTICS IS A DRUG DISCOVERY PLATFORM COMPANYBiophysical Therapeutics is a computational biology platform company with a pipeline of experimentally-validated new drugs. Primary targets are cancer, the diseases of aging (e.g., Alzheimer's disease), and aging itself.Computational biology is a hot area with start-ups in the space routinely raising tens or hundreds of millions (USD) per investment round. We are distinct in (actually) having resolved computational biology to (actual) new experimentally-validated drugs and granted patents rather than just handwaving that we will sometime in the future, which demonstrates the valuable human capital in the company. Company has raised $190k to date.Longevity is a hot area also, typically with investment rounds of tens of millions to billions (USD) for companies with longevity expertise and/or a longevity drug candidate - we have both. In the USA alone, every year of increased life expectancy is worth $38 trillion USD ($38T).Our Longevity Drug CandidateTo date, we've patents granted in USA, India, Israel, Mexico, Australia, New Zealand, Singapore, South Korea, with many others pending.In addition to inventing new drugs, we’ve discovered, as we predicted, that the emphysema drug almitrine has anticancer activity, which is ready to trial in lung cancer patients. We own a granted US patent for its anticancer use. Critically, compared to present cancer drugs, almitrine has minimal side-effects in humans.Inventiveness (especially of new drugs) is extremely rare and valuable.THE MOONSHOT THAT PAYS ITS WAYIF1 is Biophysical Therapeutics' consumer brand pertaining to anti-aging skincare, which - since sold as a cosmetic - won't require clinical trials and will (in success) yield it revenue and profit, which is something that biotech companies rarely achieve. The moonshot that pays its own way there.Face first into longevity. ## FAQ 1. **How will the $50k raised, be used?** - Hi Sam. In the present plan (which might change): $50k, the smallest permissible raise amount on Wefunder, to test whether the (patented) drug can slow human tissue aging. 2. **From LinkedIn page, there's only one team member. Which is Dr. Michael Forrest? are you a solopreneur? Why there's only you? Also, why there's no official website for this business?** - Single founder: Dr. Michael Forrest. Company now edging out of "stealth mode" (commonly employed by biopharma companies early on): website to come (will be at https://biophysicaltherapeutics.com). ## Team - Dr. Michael Forrest (Drug Inventor | CEO) - Professor George Church (Advisor) - Professor Bruno Conti (Advisor) ## Q&A - Q: Why are you crowd funding the company instead of pursuing more traditional investors? Also, what progress has the company made since launching the campaign? - Q: From LinkedIn page, there's only one team member. Which is Dr. Michael Forrest? are you a solopreneur? Why there's only you? Also, why there's no official website for this business? - A: Single founder: Dr. Michael Forrest. Company now edging out of "stealth mode" (commonly employed by biopharma companies early on): website to come (will be at https://biophysicaltherapeutics.com). - Q: How will the $50k raised, be used? - A: Hi Sam. In the present plan (which might change): $50k, the smallest permissible raise amount on Wefunder, to test whether the (patented) drug can slow human tissue aging. - Q: Has this company failed? No updates in ages, no information on website. Please update us. - Q: What is the status of this raise? - Q: is this round still being raised ? See it as oversubscribed and a lot of the questions haven’t been answered - Q: I have a few questions: 1) I am also wondering about the pharmacokinetics of say a topical application for this. Would you anticipate it would reduce wrinkles? 2) What about testing whether the drug increases life span of mice directly? This would seem to be possible. 3) Are there any plans to publish in a peer-reviewed journal? - Q: Hi Michael, Congratulations on the success so far. A few questions before I invest 1. What is your burn rate? 2. As of today what is the runaway? 3. How many team members? Could more info be shared on this? 4. When you say your first product could be cosmetic oriented, what exactly would the product be? Could you share some light? - Q: Let’s say we lower the metabolic rate of the skin with the if1 cream, does that lower the radiation rate/skin temperature? Because it could be that the inner tissues now have to increase their metabolic rate to compensate and then aging as a result lowers in the skin but increases in the rest of the body. - Q: Love what you have built. I would love to support you as a startup guru and as your Head of people . http://calendly.com/lizabethmurphy - Lizabeth https://www.linkedin.com/in/lizabethmurphymalik/ - Q: Hi there, a) What is your most recent monthly burn rate? b) What is your most recent monthly cash on hand? c) Are you raising a parallel angel or VC round simultaneously? If yes, who is investing in this round?